SCHEMBL29967106

SCHEMBL29967106

O=c1[nH]cnc2cc(F)ccc12

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 9/20 0.74
▸ CHEK1 O14757 3/20 0.64
▸ PIM1 P11309 2/20 0.64
▸ ALDH1A1 P00352 1/20 0.64
▸ RPS6KA3 P51812 1/20 0.64
▸ IP6K1 Q92551 3/20 0.56
▸ IP6K3 Q96PC2 1/20 0.56
▸ PDPK1 O15530 2/20 0.56
▸ CA12 O43570 1/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.56
▸ CA9 Q16790 1/20 0.56
▸ TNKS2 Q9H2K2 1/20 0.56
▸ KDR P35968 2/20 0.52
▸ EPHB4 P54760 2/20 0.52
▸ TEK Q02763 2/20 0.52
▸ EGFR P00533 1/20 0.52
▸ PDGFRB P09619 1/20 0.52
▸ KIT P10721 1/20 0.52
▸ FGFR1 P11362 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24819 1.00 PARP1 (0.74) PARP1CHEK1PIM1ALDH1A1RPS6KA3
SCHEMBL6922381 0.88 PARP1 (0.63) PARP1CHEK1PIM1ALDH1A1RPS6KA3
SCHEMBL29709603 0.85 PARP1 (1.00) PARP1CHEK1PIM1ALDH1A1IP6K1
SCHEMBL2191067 0.85 PARP1 (1.00) PARP1CHEK1PIM1ALDH1A1IP6K1
Hydrochloric Acid SCHEMBL30141968 0.84 PARP1 (0.96) PARP1CHEK1PIM1IP6K1IP6K3
SCHEMBL6921163 0.82 TEK (0.59) PARP1CHEK1PIM1ALDH1A1RPS6KA3
SCHEMBL2051742 0.82 IP6K1 (0.59) PARP1CHEK1PIM1ALDH1A1RPS6KA3
SCHEMBL2047492 0.79 IP6K1 (0.59) PARP1CHEK1PIM1ALDH1A1RPS6KA3
SCHEMBL5875318 0.78 IP6K1 (0.61) PARP1CHEK1PIM1ALDH1A1RPS6KA3
SCHEMBL391295 0.78 PIM1 (0.74) PARP1CHEK1PIM1ALDH1A1RPS6KA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118996447-A Phosphine-oxide substituted quinoxaline quinazolinone compound, preparation method and application thereof 南阳师范学院 2024-11-22 — — CN claimed
CN-115252554-B Preparation, composition and application of novel 4 (3H) -quinazolinone analogue/cyclic dinucleotide cGAMP co-carrier liposome in antitumor drugs 杭州星鳌生物科技有限公司 2023-08-25 — — CN claimed
CN-115702939-A Multi-target complex of cargo liposome, drug-loading platform containing multi-target complex and application of multi-target complex 杭州星鳌生物科技有限公司 2023-02-17 — — CN claimed
WO-2023011076-A1 MULTI-TARGET COMPLEX OF LOADED LIPOSOME AND DRUG-LOADED PLATFORM CONTAINING SAME AND APPLICATION 杭州星鳌生物科技有限公司 2023-02-09 — — WO claimed
CN-122029158-A EGFR inhibitors 缆图药品公司 2026-05-12 — — CN disclosed
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
WO-2025227032-A1 METHODS FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES REMIX THERAPEUTICS INC. (US) 2025-10-30 — — WO disclosed
CN-119950718-A Pharmaceutical composition containing STING agonist and application thereof 杭州星鳌生物科技有限公司 2025-05-09 — — CN disclosed
WO-2025080784-A1 EGFR INHIBITORS BLUEPRINT MEDICINES CORPORATION (US) 2025-04-17 — — WO disclosed
CN-111699176-B Quinazolinones as PARP14 inhibitors 里邦医疗公司 2025-02-14 — — CN disclosed
CN-114025755-B Therapeutic use of heterocyclic compounds as kinase inhibitors 台湾卫生研究院 2024-11-29 — — CN disclosed
CN-118996447-A Phosphine-oxide substituted quinoxaline quinazolinone compound, preparation method and application thereof 南阳师范学院 2024-11-22 — — CN disclosed
CN-115252554-B Preparation, composition and application of novel 4 (3H) -quinazolinone analogue/cyclic dinucleotide cGAMP co-carrier liposome in antitumor drugs 杭州星鳌生物科技有限公司 2023-08-25 — — CN disclosed
CN-116120326-A Alpha-methyl deoxidized duckbill alkali ketone compound and synthesis method thereof 常州大学 2023-05-16 — — CN disclosed
CN-113637011-B Myricetin derivative containing quinazoline-4 (3H) -ketone and preparation method and application thereof 贵州大学 2023-03-31 — — CN disclosed
CN-115702939-A Multi-target complex of cargo liposome, drug-loading platform containing multi-target complex and application of multi-target complex 杭州星鳌生物科技有限公司 2023-02-17 — — CN disclosed
WO-2023011076-A1 MULTI-TARGET COMPLEX OF LOADED LIPOSOME AND DRUG-LOADED PLATFORM CONTAINING SAME AND APPLICATION 杭州星鳌生物科技有限公司 2023-02-09 — — WO disclosed
WO-2022233253-A1 METHOD FOR PREPARING NEW 4(3H)-QUINAZOLINONE ANALOG, STRUCTURAL COMPOSITION THEREOF, AND USE THEREOF IN ANTITUMOR DRUGS 杭州星鳌生物科技有限公司 2022-11-10 — — WO disclosed
CN-115252554-A Preparation and composition of novel 4 (3H) -quinazolinone analogue/cyclic dinucleotide cGAMP (cyclic-gated AMP) co-carried liposome and application of liposome in antitumor drugs 杭州星鳌生物科技有限公司 2022-11-01 — — CN disclosed
CN-115260164-A Preparation method and structural composition of novel 4 (3H) -quinazolinone analogue and application of analogue in antitumor drugs 杭州星鳌生物科技有限公司 2022-11-01 — — CN disclosed
Send feedback